Related Experiment Video
Updated: Feb 27, 2026
04:54
Modified Mouse Model of Repetitive Mild Traumatic Brain Injury Incorporating Thinned-Skull Window and Fluid Percussion
Published on: April 19, 2024
1.3K
[Pseudotumor cerebri due to taking minocycline]
M Kaabour1, F Guerisse2, P Mols3
1Service des Urgences Pédiatriques, H.U.D.E.R.F.
Revue Medicale De Bruxelles
|June 28, 2017
Summary
Minocycline, an antibiotic used for acne, can cause increased intracranial pressure (ICP), a condition known as pseudotumor cerebri (PTC). This case highlights the variable prognosis of drug-induced PTC.
Area of Science:
- Neurology
- Ophthalmology
- Pharmacology
Background:
- Pseudotumor cerebri (PTC) is characterized by elevated cerebrospinal fluid (CSF) pressure without identifiable structural brain abnormalities.
- The exact pathophysiology of PTC remains unclear, despite established diagnostic criteria.
- Certain antibiotics, including minocycline, tetracycline, and doxycycline, have been linked to PTC development.
Observation:
- A 12-year-old female presented with severe headaches and diplopia, symptoms linked to minocycline use for acne treatment.
- Diagnostic imaging revealed severe papilledema and enlarged optic nerve subarachnoid spaces, indicative of PTC.
- Lumbar punctures led to clinical stabilization and symptom improvement, though papilledema persisted.
Findings:
- This case illustrates minocycline-induced PTC in a pediatric patient.
- The study reviews the physiopathology, diagnostic approaches, and management strategies for minocycline-related PTC.
- The prognosis for minocycline-induced PTC varies, ranging from spontaneous resolution to permanent vision loss.
Implications:
- Early recognition and discontinuation of causative agents like minocycline are crucial for managing drug-induced PTC.
- This case underscores the importance of considering medication side effects in the differential diagnosis of neurological symptoms.
- Further research into the mechanisms and long-term outcomes of drug-induced PTC is warranted.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
708
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
708
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:10Drugs that Destabilize Microtubules
4.1K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.1K